Location
United States, North America
Check Size
$1M - $75M
Investment Stage
Seed
Series A
Series B
Focus Areas
Health & Hospital Services
Pharmaceuticals
Medical Devices
About Investor
Carl L. Gordon is a Managing Partner at OrbiMed, a New York City–based global healthcare investment firm. His investments range from $1M to $75.0M, with a sweet spot around $4.0M, targeting pharmaceuticals, medical devices, and healthcare services at seed through Series B stages. He is one of the founding members of OrbiMed and has decades of experience investing in life sciences.
Previous investments
ENYO Pharma
43M |2024
47M |2018
BlossomHill Therapeutics
100M |2024
71M |2021
RayThera
110M |2025
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,JR
JJ Richa
United States, North America
$50K - $1M
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP
Grow with the Right Investors
This profile is just one example. Our AI matches you with the investors who best fit your stage, industry, and vision.
Start Matching For Free